Drug Profile
Quabodepistat - Otsuka Pharmaceutical
Alternative Names: OPC-167832Latest Information Update: 25 Mar 2024
Price :
$50
*
At a glance
- Originator Otsuka Pharmaceutical; Otsuka Pharmaceutical Development & Commercialization
- Class 2 ring heterocyclic compounds; Antibacterials; Antituberculars; Fluorobenzenes; Piperidines; Small molecules
- Mechanism of Action DprE1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Tuberculosis